NASDAQ: BCTX - BriaCell Therapeutics Corp.

Lønnsomhet i seks måneder: -65.46%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan BriaCell Therapeutics Corp.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types.

flere detaljer
It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-02-24
ISIN CA10778Y3023
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://briacell.com
Цена ао 4.18
Prisendring per dag: -3.42% (3.8)
Prisendring per uke: -16.97% (4.42)
Prisendring per måned: -37.8% (5.9)
Prisendring over 3 måneder: -75.1% (14.736)
Prisendring over seks måneder: -65.46% (10.6245)
Prisendring per år: +5.76% (3.47)
Prisendring over 3 år: -51.63% (7.5866)
Prisendring over 5 år: +5 838.51% (0.0618)
Prisendring over 10 år: 0% (3.67)
Prisendring siden begynnelsen av året: -56.39% (8.415)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV -67.57 0
P/E 0 0
EV/EBITDA -37.84 0
Total: 2.25

Effektivitet

Navn Betydning Karakter
ROA, % -29.01 0
ROE, % 155.55 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % -440.84 0
Lønnsomhet EPS, % -115.17 0
Total: 2
Flere detaljer

Institusjoner Volum Dele, %
Lynwood Capital Management Inc. 1580645 9.89
Wasatch Advisors LP 267410 1.67
Redmond Asset Management, LLC 133569 0.84
Harrison (K.J.) & Partners, Inc. 80715 0.51
Morgan Stanley 64801 0.41
Susquehanna International Group, LLP 62322 0.39
Bank of Montreal/Can/ 54116 0.34
Summit Trail Advisors, LLC 35000 0.22
Onyx Bridge Wealth Group, LLC 30000 0.19
Natixis 22281 0.14



Veileder Stillingstittel Betaling Fødselsår
Dr. William V. Williams M.D. CEO, President & Director 785.3k 1955 (70 år)
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. CFO & Corporate Secretary 304.46k 1973 (52 år)
Dr. Miguel A. Lopez-Lago Ph.D. Chief Scientific Officer 298.9k 1969 (56 år)
Dr. Giuseppe Del Priore M.D., M.P.H., MPH Chief Medical Officer 492.5k 1962 (63 år)
Dr. Charles Louis Wiseman FACP, M.D. Founder, Principal Research Advisor & Member of Scientific Advisory Board 241.14k 1946 (79 år)

Adresse: Canada, West Vancouver. BC VT X, Bellevue Centre - åpne i Google maps, åpne Yandex-kart
Nettsted: https://briacell.com